CL012_140: A Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study to Evaluate the Safetyand Efficacy of CCX140-B in Subjects with Focal Segmental Glomerulosclerosis (FSGS)

Project: Research project

Project Details

Description

CL012_140: A Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study to Evaluate the Safety and Efficacy of CCX140-B in Subjects with Focal Segmental Glomerulosclerosis (FSGS)
StatusActive
Effective start/end date8/1/1812/31/22

Funding

  • ChemoCentryx, Inc.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.